Found: 121
Select item for more details and to access through your institution.
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E504, doi. 10.1002/ajh.24548
- By:
- Publication type:
- Article
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
- By:
- Publication type:
- Article
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
- By:
- Publication type:
- Article
Prevalence and Antibiotic Resistance of Salmonella and Campylobacter Isolates from Raw Chicken Breasts in Retail Markets in the United States and Comparison to Data from the Plant Level.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 3, p. 642, doi. 10.3390/life13030642
- By:
- Publication type:
- Article
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.842200
- By:
- Publication type:
- Article
Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 5, p. 663, doi. 10.1002/jcph.850
- By:
- Publication type:
- Article
Meatoplasty transposition flaps.
- Published in:
- Laryngoscope, 1972, v. 82, n. 3, p. 404, doi. 10.1288/00005537-197203000-00007
- By:
- Publication type:
- Article
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 10, p. 755, doi. 10.1038/sj.cgt.7700626
- By:
- Publication type:
- Article
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: Preclinical studies in myeloma.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 5, p. 361, doi. 10.1038/sj.cgt.7700321
- By:
- Publication type:
- Article
Improvements in Renal Function with Selinexor in Relapsed/Refractory Multiple Myeloma: Post-hoc Analyses from the STORM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e118, doi. 10.1016/j.clml.2019.09.196
- By:
- Publication type:
- Article
Ex vivo sensitivity to venetoclax is predictive of clinical activity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e114, doi. 10.1016/j.clml.2019.09.189
- By:
- Publication type:
- Article
Synergistic Drug Combinations to Overcome Venetoclax Resistance in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e120, doi. 10.1016/j.clml.2019.09.198
- By:
- Publication type:
- Article
Effect of Age on the Safety and Efficacy of Selinexor in Patients with Relapsed Refractory Multiple Myeloma: A Post-hoc Analysis of the STORM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e117, doi. 10.1016/j.clml.2019.09.195
- By:
- Publication type:
- Article
The contribution of proteasome subunits to Myeloma cell viability and proteasome inhibitor sensitivity.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e77, doi. 10.1016/j.clml.2019.09.122
- By:
- Publication type:
- Article
Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.090
- By:
- Publication type:
- Article
Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.149
- By:
- Publication type:
- Article
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S335, doi. 10.1016/j.clml.2017.07.151
- By:
- Publication type:
- Article
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Activity of 129 single-agent drugs in 228 phase I and II clinical trials in multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 19, doi. 10.1016/j.clml.2012.08.009
- By:
- Publication type:
- Article
An Open-Label Single-Arm Pilot Phase II Study (PX-171-003-A0) of Low-Dose, Single-Agent Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 310, doi. 10.1016/j.clml.2012.08.003
- By:
- Publication type:
- Article
Can Prayer and Intentionality Be Researched? Should They Be? COUNTERPOINT: Miracles On Demand; Prayer and the Causation of Healing.
- Published in:
- Alternative Therapies in Health & Medicine, 1997, v. 3, n. 6, p. 92
- By:
- Publication type:
- Article
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1.
- Published in:
- FASEB Journal, 2010, v. 24, n. 3, p. 947, doi. 10.1096/fj.09-140806
- By:
- Publication type:
- Article
Neutrophilic myelofibrosis presenting as philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 1990, v. 34, n. 1, p. 59, doi. 10.1002/ajh.2830340113
- By:
- Publication type:
- Article
Spinal discord.
- Published in:
- Nature, 1987, v. 327, n. 6119, p. 196, doi. 10.1038/327196a0
- By:
- Publication type:
- Article
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Functional validation of TERT and TERC variants of uncertain significance in patients with short telomere syndromes.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
- By:
- Publication type:
- Article
Boronizing protects metals against wear.
- Published in:
- Advanced Materials & Processes, 1997, v. 151, n. 3, p. 23
- By:
- Publication type:
- Article
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 4, p. 316, doi. 10.1111/ejh.12491
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 3, p. 200, doi. 10.1111/j.1600-0609.2010.01469.x
- By:
- Publication type:
- Article
CELL BIOLOGY - IMMUNOLOGY - PATHOLOGY 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion.
- Published in:
- Kidney International, 2004, v. 65, n. 2, p. 499, doi. 10.1111/j.1523-1755.2004.00415.x
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat.
- Published in:
- Kidney International, 2003, v. 64, n. 5, p. 1605, doi. 10.1046/j.1523-1755.2003.00254.x
- By:
- Publication type:
- Article
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury.
- Published in:
- Kidney International, 2002, v. 62, n. 4, p. 1249, doi. 10.1111/j.1523-1755.2002.kid580.x
- By:
- Publication type:
- Article
Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury.
- Published in:
- 2002
- By:
- Publication type:
- journal article